SG11201707157PA - Methods for enhancing the specific uptake of botulinum neurotoxins into cells - Google Patents

Methods for enhancing the specific uptake of botulinum neurotoxins into cells

Info

Publication number
SG11201707157PA
SG11201707157PA SG11201707157PA SG11201707157PA SG11201707157PA SG 11201707157P A SG11201707157P A SG 11201707157PA SG 11201707157P A SG11201707157P A SG 11201707157PA SG 11201707157P A SG11201707157P A SG 11201707157PA SG 11201707157P A SG11201707157P A SG 11201707157PA
Authority
SG
Singapore
Prior art keywords
enhancing
cells
methods
specific uptake
botulinum neurotoxins
Prior art date
Application number
SG11201707157PA
Inventor
Claudia Jatzke
Karl-Heinz Eisele
Gerd Mander
Klaus Fink
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of SG11201707157PA publication Critical patent/SG11201707157PA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058Neurological cells
    • AHUMAN NECESSITIES
    • A47FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
    • A47LDOMESTIC WASHING OR CLEANING; SUCTION CLEANERS IN GENERAL
    • A47L9/00Details or accessories of suction cleaners, e.g. mechanical means for controlling the suction or for effecting pulsating action; Storing devices specially adapted to suction cleaners or parts thereof; Carrying-vehicles specially adapted for suction cleaners
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09JADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J7/00Adhesives in the form of films or foils
    • C09J7/40Adhesives in the form of films or foils characterised by release liners
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0619Neurons
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/30Polarising elements
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1335Structural association of cells with optical devices, e.g. polarisers or reflectors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B38/00Ancillary operations in connection with laminating processes
    • B32B38/10Removing layers, or parts of layers, mechanically or chemically
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B43/00Operations specially adapted for layered products and not otherwise provided for, e.g. repairing; Apparatus therefor
    • B32B43/006Delaminating
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/11Methods of delaminating, per se; i.e., separating at bonding face
    • Y10T156/1126Using direct fluid current against work during delaminating
    • Y10T156/1132Using vacuum directly against work during delaminating
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/11Methods of delaminating, per se; i.e., separating at bonding face
    • Y10T156/1168Gripping and pulling work apart during delaminating
    • Y10T156/1174Using roller for delamination [e.g., roller pairs operating at differing speeds or directions, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/11Methods of delaminating, per se; i.e., separating at bonding face
    • Y10T156/1168Gripping and pulling work apart during delaminating
    • Y10T156/1195Delaminating from release surface
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/19Delaminating means
    • Y10T156/1928Differential fluid pressure delaminating means
    • Y10T156/1944Vacuum delaminating means [e.g., vacuum chamber, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/19Delaminating means
    • Y10T156/195Delaminating roller means
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/19Delaminating means
    • Y10T156/1994Means for delaminating from release surface
SG11201707157PA 2015-03-04 2016-03-03 Methods for enhancing the specific uptake of botulinum neurotoxins into cells SG11201707157PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15157549 2015-03-04
PCT/EP2016/054552 WO2016139308A1 (en) 2015-03-04 2016-03-03 Methods for enhancing the specific uptake of botulinum neurotoxins into cells

Publications (1)

Publication Number Publication Date
SG11201707157PA true SG11201707157PA (en) 2017-09-28

Family

ID=52705963

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201707157PA SG11201707157PA (en) 2015-03-04 2016-03-03 Methods for enhancing the specific uptake of botulinum neurotoxins into cells

Country Status (16)

Country Link
US (1) US10725025B2 (en)
EP (1) EP3265808B1 (en)
JP (1) JP6670842B2 (en)
KR (1) KR102418939B1 (en)
CN (1) CN108064310B (en)
AU (1) AU2016227655B2 (en)
BR (1) BR112017018962A2 (en)
CA (1) CA2978225C (en)
ES (1) ES2822905T3 (en)
HK (1) HK1249147A1 (en)
IL (1) IL254181B (en)
MX (1) MX2017011195A (en)
RU (1) RU2684404C2 (en)
SG (1) SG11201707157PA (en)
TW (1) TWI704156B (en)
WO (1) WO2016139308A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ588029A (en) * 2008-03-14 2012-12-21 Allergan Inc Immuno-based botulinum toxin serotype a activity assays
JP6608357B2 (en) 2013-06-28 2019-11-20 メルツ ファルマ ゲーエムベーハー ウント コンパニー カーゲーアーアー Means and methods for determining biological activity of neurotoxin polypeptides in cells
TWI704156B (en) * 2015-03-04 2020-09-11 德商曼茲法瑪股份有限公司 Methods for enhancing the specific uptake of botulinum neurotoxins into cells
CN115826239A (en) 2017-10-16 2023-03-21 奥里姆光学有限公司 High-efficient compact head-mounted display system
EP3752128A1 (en) * 2018-02-16 2020-12-23 Bontana Therapies Gmbh Nucleic acid-based botulinum neurotoxin for therapeutic use
CN111621525B (en) * 2020-06-18 2021-04-23 中赛干细胞基因工程有限公司 Application of STX1B gene in promoting growth and differentiation of human adipose-derived mesenchymal stem cells

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60032367T3 (en) * 1999-08-25 2011-03-10 Allergan, Inc., Irvine ACTIVE RECOMBINANT NEUROTOXINE
US20080032931A1 (en) * 1999-08-25 2008-02-07 Steward Lance E Activatable clostridial toxins
FI20070808A0 (en) * 2007-10-25 2007-10-25 Mart Saarma Split variants of GDNF and uses thereof
NZ588029A (en) * 2008-03-14 2012-12-21 Allergan Inc Immuno-based botulinum toxin serotype a activity assays
WO2010085473A1 (en) * 2009-01-20 2010-07-29 Trustees Of Tufts College Methods for the delivery of toxins or enzymatically active portions thereof
EP2398897B1 (en) 2009-02-20 2017-06-28 Cellular Dynamics International, Inc. Methods and compositions for the differentiation of stem cells
KR101720961B1 (en) 2009-02-27 2017-03-29 셀룰러 다이내믹스 인터내셔널, 인코포레이티드 Differentiation of pluripotent cells
AU2010223910B2 (en) 2009-03-13 2015-03-12 Allergan, Inc. Cells useful for immuno-based Botulinum toxin serotype A activity assays
WO2011025852A1 (en) 2009-08-28 2011-03-03 Cellular Dynamics International, Inc. Identifying genetic variation in affected tissues
ES2539487T3 (en) 2009-11-04 2015-07-01 Cellular Dynamics International, Inc. Episomic reprogramming with chemical compounds
CA2780932A1 (en) * 2009-11-18 2011-05-26 Merz Pharma Gmbh & Co. Kgaa Assay for quantifying clostridial neurotoxin
US9487752B2 (en) 2011-03-30 2016-11-08 Cellular Dynamics International, Inc. Priming of pluripotent stem cells for neural differentiation
WO2014079878A1 (en) 2012-11-21 2014-05-30 Merz Pharma Gmbh & Co. Kgaa Means and methods for determination of botulinum neurotoxin biological activity
JP6608357B2 (en) 2013-06-28 2019-11-20 メルツ ファルマ ゲーエムベーハー ウント コンパニー カーゲーアーアー Means and methods for determining biological activity of neurotoxin polypeptides in cells
US10634683B2 (en) * 2014-11-21 2020-04-28 Merz Pharma Gmbh & Co. Kgaa Methods for the determination of the biological activities of neurotoxin polypeptides
CN107207586B (en) * 2014-12-19 2021-07-13 莫茨药物股份两合公司 Device and method for determining biological activity of BoNT/E in cells
TWI704156B (en) * 2015-03-04 2020-09-11 德商曼茲法瑪股份有限公司 Methods for enhancing the specific uptake of botulinum neurotoxins into cells

Also Published As

Publication number Publication date
KR102418939B1 (en) 2022-07-07
CN108064310A (en) 2018-05-22
RU2017130580A (en) 2019-04-05
EP3265808A1 (en) 2018-01-10
AU2016227655B2 (en) 2021-08-19
KR20170121194A (en) 2017-11-01
WO2016139308A1 (en) 2016-09-09
RU2017130580A3 (en) 2019-04-05
JP2018506985A (en) 2018-03-15
IL254181A0 (en) 2017-10-31
CA2978225C (en) 2022-09-13
ES2822905T3 (en) 2021-05-05
JP6670842B2 (en) 2020-03-25
BR112017018962A2 (en) 2018-04-24
AU2016227655A1 (en) 2017-09-14
MX2017011195A (en) 2017-11-09
IL254181B (en) 2020-03-31
CA2978225A1 (en) 2016-09-09
US10725025B2 (en) 2020-07-28
RU2684404C2 (en) 2019-04-09
CN108064310B (en) 2021-06-11
HK1249147A1 (en) 2018-10-26
EP3265808B1 (en) 2020-08-26
US20180238861A1 (en) 2018-08-23
TW201639875A (en) 2016-11-16
TWI704156B (en) 2020-09-11

Similar Documents

Publication Publication Date Title
HK1249119A1 (en) Engineered botulinum neurotoxin
IL255157B (en) Microfluidic cell culture
IL263058A (en) Engineered botulinum neurotoxins
DK3386454T3 (en) Forbinding til hudpleje i fugtigt miljø
PL3399031T3 (en) Detergent composition comprising subtilase variants
HK1249147A1 (en) Methods for enhancing the specific uptake of botulinum neurotoxins into cells
GB201621111D0 (en) Neurotoxins
HK1253068A1 (en) Microfluidic cell culture
DK3347540T3 (en) Bærer til et lineært loftspanel
PL3766582T3 (en) Cell culture
IL287719A (en) Stabilized thrombin
ZA201802390B (en) Improved fermenter
HK1259489A1 (en) Proenzyme composition
IL259259A (en) Proenzyme composition
DK3393580T3 (en) Apparat til infrarødsvejsning
GB2541635B (en) Indenters
SG10201507842WA (en) Grinding method
GB201502044D0 (en) Determining nagalase concentration